IRCM U1194 INSERM, Tumor Microenvironment and Resistance to Treatment Lab
IRCM U1194 INSERM, Tumor Microenvironment and Resistance to Treatment Lab
Explore linked clinical trials.1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| New Biomarkers in Pancreatic Cancer Using EXPEL Concept | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, disease, endocrine system disorder, malignant endocrine neoplasm, neoplasm, pancreas disorder, pancreatic neoplasm | Recruiting | Not stated | 2026-06-18 | NCT03791073 |